Literature DB >> 8410289

Dopaminergic D2 receptor SPECT imaging in Rett syndrome: increase of specific binding in striatum.

C Chiron1, C Bulteau, C Loc'h, C Raynaud, B Garreau, A Syrota, B Mazière.   

Abstract

A dopamine deficiency has been implicated in Rett syndrome, a progressive encephalopathy in girls that involves movement, tonus and cognitive disorders. To test the hypothesis that striatal D2 receptors increase in number in early stages of the disease, we measured the binding potential of 123I-Iodolisuride, a specific D2 ligand, in eleven Rett children aged 4-15 yr (7.9 +/- 3.5 yr) (mean +/- s.d.) and eight control subjects aged 3.5-13 yr (8.1 +/- 3.8 yr) who exhibited other neurological disorders. Regional cerebral blood flow (rCBF) was also measured with SPECT using 133Xe. The binding potential for 123I-ILIS and D2 receptors was significantly higher in Rett (0.45) than in controls (0.23) (p < 0.01). An increase in 123I-ILIS binding due to increased rCBF in patients' striata was excluded. Our results are consistent with a higher density of D2 receptors in young patients suffering from Rett syndrome because of reduced dopaminergic neurotransmission.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8410289

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  9 in total

Review 1.  Altered trajectories of neurodevelopment and behavior in mouse models of Rett syndrome.

Authors:  Elizabeth S Smith; Dani R Smith; Charlotte Eyring; Maria Braileanu; Karen S Smith-Connor; Yew Ei Tan; Amanda Y Fowler; Gloria E Hoffman; Michael V Johnston; Sujatha Kannan; Mary E Blue
Journal:  Neurobiol Learn Mem       Date:  2018-11-29       Impact factor: 2.877

Review 2.  Mouse models of neurodevelopmental disease of the basal ganglia and associated circuits.

Authors:  Samuel S Pappas; Daniel K Leventhal; Roger L Albin; William T Dauer
Journal:  Curr Top Dev Biol       Date:  2014       Impact factor: 4.897

Review 3.  Dysfunction of the corticostriatal pathway in autism spectrum disorders.

Authors:  Wei Li; Lucas Pozzo-Miller
Journal:  J Neurosci Res       Date:  2019-11-22       Impact factor: 4.164

4.  Reward circuitry dysfunction in psychiatric and neurodevelopmental disorders and genetic syndromes: animal models and clinical findings.

Authors:  Gabriel S Dichter; Cara A Damiano; John A Allen
Journal:  J Neurodev Disord       Date:  2012-07-06       Impact factor: 4.025

5.  Analysis of the Serotonergic System in a Mouse Model of Rett Syndrome Reveals Unusual Upregulation of Serotonin Receptor 5b.

Authors:  Steffen Vogelgesang; Sabine Niebert; Ute Renner; Wiebke Möbius; Swen Hülsmann; Till Manzke; Marcus Niebert
Journal:  Front Mol Neurosci       Date:  2017-03-08       Impact factor: 5.639

6.  Correlation of dystonia severity and iron accumulation in Rett syndrome.

Authors:  Tz-Yun Jan; Lee-Chin Wong; Ming-Tao Yang; Chien-Feng Judith Huang; Chia-Jui Hsu; Steven Shinn-Forng Peng; Wen-Yih Isaac Tseng; Wang-Tso Lee
Journal:  Sci Rep       Date:  2021-01-12       Impact factor: 4.379

Review 7.  Multimodal Neuroimaging in Rett Syndrome With MECP2 Mutation.

Authors:  Yu Kong; Qiu-Bo Li; Zhao-Hong Yuan; Xiu-Fang Jiang; Gu-Qing Zhang; Nan Cheng; Na Dang
Journal:  Front Neurol       Date:  2022-02-23       Impact factor: 4.003

8.  Improvement of the Rett syndrome phenotype in a MeCP2 mouse model upon treatment with levodopa and a dopa-decarboxylase inhibitor.

Authors:  Karolina Szczesna; Olga de la Caridad; Paolo Petazzi; Marta Soler; Laura Roa; Mauricio A Saez; Stéphane Fourcade; Aurora Pujol; Rafael Artuch-Iriberri; Marta Molero-Luis; August Vidal; Dori Huertas; Manel Esteller
Journal:  Neuropsychopharmacology       Date:  2014-06-11       Impact factor: 7.853

Review 9.  Dopaminergic Dysregulation in Syndromic Autism Spectrum Disorders: Insights From Genetic Mouse Models.

Authors:  Polina Kosillo; Helen S Bateup
Journal:  Front Neural Circuits       Date:  2021-07-23       Impact factor: 3.492

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.